CO2PERATE has 15 PhD research projects (P1-P15), divided into 4 work packages (WP1-4). Click on the project links to access the individual project pages.
Main goals: Efficient non-precious metal catalysts for the formation of carboxyl and ester motifs from CO2 and sustainable starting materials.
P1: Catalytic carboxylation of saturated hydrocarbons with CO2 en route to fatty acids (WP1) >
P2: Catalytic conversion of lignin to aryl carboxylic acids with CO2 (WP1)
P3: Novel catalytic composites for the use of CO2 as a one carbon synthon for organic synthesis (WPs 1 and 3)
P4: C–C bond forming reactions with CO2 using Lewis acidic zeolite catalysts (WP1)
P5: Computational analysis of CO2 –based carboxylation of hydrocarbons (WP1)
P13: Catalytic alkoxycarbonylation reactions of unsaturated hydrocarbons with CO2 (WP1)
Main goals: Homogeneous and immobilized catalysts for the efficient and enantioselective formation of carbamate motifs from CO2.
P6: Efficient synthesis of fluorine-containing oxazolidinones from atmospheric CO2 (WP2)
P7: Multicomponent functionalization of π-systems incorporating CO2 (WP2)
P8: Computational analysis of symmetric and asymmetric oxazolidinone formation from CO2 (WP2)
Main goals: Efficient non-precious homogeneous and heterogeneous catalysts for the formation of amides and ketones via carbonylation and aminocarbonylation processes with CO2.
P10: Computational insights into the conversion of CO2 to CO and carbonylation reactions (WP3)
P14: Theoretical studies on catalytic alkoxycarbonylation and carbonylation reactions with CO2 (WP1)
P15: Development of catalysts for aminocarbonylation reactions of olefins with CO2 (WP3)
Main goals: New versatile technologies for the isotopic labelling of chemicals, pharmaceuticals, and proteins with 11CO2, 13CO2, and 14CO2.
P9: Efficient Methods for CO2 Conversion to CO and PET labelling of pharmaceuticals (WP3 and WP4)
P11: Catalytic carboxylation techniques with isotopically labelled CO2 (WP4)
P12: Development of late-stage and rapid carboxylation techniques with 14CO2 in drug development programs (WP4)
Sort after country